Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CALCIBIND

CELLULOSE SODIUM PHOSPHATE

Standard Dose
2.5GM/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview CALCIBIND is listed in Drugs@FDA under application 018757 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient CELLULOSE SODIUM PHOSPHATE Form and strength POWDER;ORAL - 2.5GM/PACKET Sponsor MISSION PHARMA Submission history Latest submission status date: 2002-06-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview CALCIBIND is listed in Drugs@FDA under application 018757 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient CELLULOSE SODIUM PHOSPHATE Form and strength POWDER;ORAL - 2.5GM/PACKET Sponsor MISSION PHARMA Submission history Latest submission status date: 2002-06-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.